Arthritis research & therapy · 2004
Interleukin-7 deficiency in rheumatoid arthritis.
КомментарийСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leonard Warren J
Аннотация
Interleukin-7 (IL-7) is a stromal factor that is crucial for the development of T lymphocytes in humans and mice, and also B lymphocytes in mice. IL-7 can act as a T cell growth factor as well as a critical anti-apoptotic survival factor. The essential non-redundant role of this cytokine for T cell development in vivo is indicated by the phenotype of murine knockout models as well as by humans with a T-B+NK+ form of severe combined immunodeficiency (SCID) resulting from mutations in IL-7 receptor alpha chain. IL-7 deficiency has now been found in patients with rheumatoid arthritis, a finding that relates not only to the T-lymphocyte status in this disease but also to the ability of patients with rheumatoid arthritis to recover from therapy-induced lymphopenia.
Предметные рубрики MeSH
Antirheumatic AgentsArthritis, RheumatoidAutoimmune DiseasesBone MarrowBone Marrow TransplantationCD4-Positive T-LymphocytesFemaleGene Rearrangement, T-LymphocyteHumansInterleukin-7Lymphocyte DepletionLymphopeniaMaleReceptors, Interleukin-7Severe Combined ImmunodeficiencyStromal CellsTumor Necrosis Factor-alpha